GB202017649D0 - Polypeptide - Google Patents

Polypeptide

Info

Publication number
GB202017649D0
GB202017649D0 GBGB2017649.1A GB202017649A GB202017649D0 GB 202017649 D0 GB202017649 D0 GB 202017649D0 GB 202017649 A GB202017649 A GB 202017649A GB 202017649 D0 GB202017649 D0 GB 202017649D0
Authority
GB
United Kingdom
Prior art keywords
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2017649.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Autolus Ltd
Original Assignee
Autolus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autolus Ltd filed Critical Autolus Ltd
Priority to GBGB2017649.1A priority Critical patent/GB202017649D0/en
Publication of GB202017649D0 publication Critical patent/GB202017649D0/en
Priority to PCT/GB2021/052893 priority patent/WO2022096899A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
GBGB2017649.1A 2020-11-09 2020-11-09 Polypeptide Ceased GB202017649D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2017649.1A GB202017649D0 (en) 2020-11-09 2020-11-09 Polypeptide
PCT/GB2021/052893 WO2022096899A1 (en) 2020-11-09 2021-11-09 Viral spike proteins and fusion thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2017649.1A GB202017649D0 (en) 2020-11-09 2020-11-09 Polypeptide

Publications (1)

Publication Number Publication Date
GB202017649D0 true GB202017649D0 (en) 2020-12-23

Family

ID=74046320

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2017649.1A Ceased GB202017649D0 (en) 2020-11-09 2020-11-09 Polypeptide

Country Status (2)

Country Link
GB (1) GB202017649D0 (en)
WO (1) WO2022096899A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112608945A (en) * 2021-01-17 2021-04-06 昆明医科大学 Modified PPP1R12A circular RNA vector and application thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023019309A1 (en) * 2021-08-17 2023-02-23 Monash University Vaccine compositions
CN113755421B (en) * 2021-09-28 2024-04-12 梦芊细胞因子有限公司 Oral vaccine and antibody enhancer for COVID-19

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE043492T2 (en) 2005-08-23 2019-08-28 Univ Pennsylvania Rna containing modified nucleosides and methods of use thereof
CA2693899A1 (en) * 2007-07-19 2009-01-22 Novavax, Inc. Chimeric varicella zoster virus-virus like particles
GB201504840D0 (en) 2015-03-23 2015-05-06 Ucl Business Plc Chimeric antigen receptor
GB201603372D0 (en) * 2016-02-26 2016-04-13 Ucl Business Plc Cell
WO2017176596A1 (en) * 2016-04-04 2017-10-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and coronaviruses
GB201707779D0 (en) * 2017-05-15 2017-06-28 Autolus Ltd Cell
GB2594365B (en) * 2020-04-22 2023-07-05 BioNTech SE Coronavirus vaccine

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112608945A (en) * 2021-01-17 2021-04-06 昆明医科大学 Modified PPP1R12A circular RNA vector and application thereof
CN112608945B (en) * 2021-01-17 2022-09-27 昆明医科大学 Modified PPP1R12A circular RNA vector and application thereof

Also Published As

Publication number Publication date
WO2022096899A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
GB202007441D0 (en) Polypeptide
GB202017649D0 (en) Polypeptide
IL288412A (en) Peptides
IL288419A (en) Recombinant herpesvirales vector
IL289122A (en) Polypeptides
IL289119A (en) Polypeptides
GB202007532D0 (en) Polypeptides
IL308465A (en) Sars-cov-2 polypeptides
GB201810052D0 (en) Polypeptide
GB202119034D0 (en) Polypeptide
IL299811A (en) Polypeptide
GB202105924D0 (en) Polypeptide
GB202103001D0 (en) Polypeptide
GB202100648D0 (en) Polypeptide
GB202019879D0 (en) Polypeptide
GB202013372D0 (en) Polypeptide
GB202011813D0 (en) Polypeptide
GB202005333D0 (en) Polypeptide
GB202319601D0 (en) Polypeptide
GB202102598D0 (en) An isolated polypeptide
IL311184A (en) Polypeptides
GB202111640D0 (en) Polypeptides
GB202113858D0 (en) Peptides
GB202110693D0 (en) Peptides
GB202102758D0 (en) Modified polypeptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)